Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Cryoport Inc (NQ: CYRX )

52.50 USD +0.41 (+0.79%)
Official Closing Price Updated: 7:28 PM EST, Mar 5, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Cryoport Inc

< Previous 1 2 3 4 5 Next >
Cryoport Announces Appointment of Linda Baddour to its Board of Directors
Ms. Baddour brings over twenty years of experience across healthcare, life sciences and pharmaceuticals 
From PR Newswire
Cryoport Reports Record Results for Full Year 2020
- Fourth quarter revenue increased 423% to $48.4 million, annual revenue increased 132% to $78.7 million 
From PR Newswire
Cryoport to Report Fourth Quarter and Fiscal Year 2020 Financial Results on March 1, 2021
Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences industry, today announced that the Company will... 
From PR Newswire
Cryoport Launches Environmental, Social, and Governance (ESG) Program
- Over 118 million pounds of Green House Gas emissions avoided in 2020 
From PR Newswire
Blackstone Converts $51 million of Cryoport Series C Preferred Stock Into Common Stock
Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences industry, today announced that funds affiliated with... 
From PR Newswire
Cryoport Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters to Purchase Additional Shares
Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences industry, today announced the closing of an... 
From PR Newswire
Cryoport Announces Pricing of Public Offering of Common Stock
Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences industry, today announced the pricing of its... 
From PR Newswire
Cryoport Announces Proposed Public Offering of Common Stock
Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences industry, today announced that it intends to offer... 
From PR Newswire
Cryoport and CCRM Fertility Enter Into Agreement
Cryoport's temperature-controlled supply chain management platform will support Colorado Center for Reproductive Medicine, a leading United States. fertility clinic 
From PR Newswire
Cryoport Reports 2020 Third-Quarter Results
- Acquired MVE Biological Solutions and CRYOPDP advancing Cryoport's position as the global leader in temperature-controlled supply chain solutions for the life sciences industry 
From PR Newswire
Petrichor Closes Oversubscribed Fund I at $410 Million
Petrichor Healthcare Capital Management (“Petrichor”), a private equity firm that makes structured investments in the healthcare sector, today announced the final close of Petrichor Opportunities Fund... 
From Business Wire News Releases
Cryoport to Report Third Quarter 2020 Financial Results on November 5, 2020
Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), a global leader in life sciences solutions, today announced that the Company will report financial results for the third quarter ended... 
From PR Newswire
Cryoport Completes Acquisitions of MVE Biological Solutions and CRYOPDP
Cryoport fortifies its position as a leading global provider of temperature-controlled life sciences solutions with a combined revenue run rate of over $160 million 
From PR Newswire
Chart Industries Expands Liquid Hydrogen and LNG Business with Strategic Agreements
From GlobeNewswire News Releases
Chart Industries Signs Definitive Agreement to Divest Cryobiological Products Business for $320 Million to Cryoport, Inc.
From GlobeNewswire News Releases
Cryoport Announces Agreement to Acquire MVE Biological Solutions from Chart Industries
Cryoport will become a leading global provider of cryogenic life sciences solutions 
From PR Newswire
Thinking about trading options or stock in CryoPort Inc, Catabasis Pharmaceuticals Inc, Wayfair, Novavax, Inc., or Thermo Fisher Scientific Inc.?
InvestorsObserver issues critical PriceWatch Alerts for CYRX, CATB, W, NVAX, and TMO. 
From PR Newswire
Cryoport Expands Global Supply Chain Platform by Signing Agreement to Acquire CRYOPDP
Acquisition will expand Cryoport's presence in both the EMEA and APAC regions and broaden Cryoport's range of temperature-controlled supply chain solutions for the life sciences; Upon closing, the... 
From PR Newswire
Cryoport Reports 2020 Second-Quarter Results
Revenue from commercial therapies increased 38% over the prior year 
From PR Newswire
MEDIPAL HOLDINGS Partners with CRYOPORT to Bring Temperature-Controlled Supply Chain Solutions to the Japanese Market
Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport"), a global leader in life sciences supply chain solutions, and MEDIPAL HOLDINGS CORPORATION (7459:JP), ("MEDIPAL") Japan's leading pharma wholesaler and... 
From PR Newswire
Cryoport to Report Second Quarter 2020 Financial Results on August 6, 2020
Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), a global leader in life sciences solutions, today announced that the Company will report financial results for the second quarter ended June... 
From PR Newswire
Cryoport, Inc. Prices $100.0 Million Convertible Senior Notes Offering
Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport") today announced the pricing on May 20, 2020 of its offering of $100.0 million in aggregate principal amount of 3.00% convertible senior notes due 2025 (the... 
From PR Newswire
Cryoport, Inc. Announces Proposed Convertible Senior Notes Offering
Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport") today announced its intention to offer, subject to market and other conditions, $100.0 million in aggregate principal amount of convertible senior notes due... 
From PR Newswire
/C O R R E C T I O N -- Cryoport, Inc./
Cryoport, Inc. (NASDAQ: CYRX) (NASDAQ: CYRXW) ("Cryoport"), a global leader in life sciences solutions, today announced financial results for the three-month period ended March 31, 2020. 
From PR Newswire
Cryoport Revenue Grows 47% for First Quarter 2020
Revenue from commercial therapies increased 110% over the prior year 
From PR Newswire
Cryoport to Report First Quarter 2020 Financial Results on May 7, 2020
Cryoport, Inc. (NASDAQ: CYRX) (NASDAQ: CYRXW) ("Cryoport" or the "Company"), a global leader in life sciences solutions, today announced that the Company will report financial results for the first... 
From PR Newswire
Cryoport Reports Record Revenue for Fiscal Year 2019
Revenue grows 73% year over year 
From PR Newswire
Cryoport to Report Fourth Quarter and Fiscal Year 2019 Financial Results on March 5, 2020
Cryoport, Inc. (NASDAQ: CYRX) (NASDAQ: CYRXW) ("Cryoport" or the "Company"), a global leader in life sciences solutions, today announced that the Company will report financial results for the fourth... 
From PR Newswire
Cryoport and Inception Fertility Enter Into Agreement
Cryoport's temperature-controlled supply chain management platform will support global logistics for The Prelude Network, the largest network of fertility centers in the U.S. 
From PR Newswire
Cryoport Announces Preliminary Fourth Quarter and Full Year 2019 Revenue
2019 Revenue Grows 73%, BioPharma Revenue Grows 64% 
From PR Newswire
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.